Engineers Gate Manager LP Orchard Therapeutics PLC Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $21,228 - $45,792	-30,326 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $35,178 - $67,626	30,326 New	30,326 $40,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $125,355 - $196,725	-30,500 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$5.75 - $11.99 $100,625 - $209,825	17,500 Added 134.62%	30,500 $183,000
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $73,450 - $204,230	13,000 New	13,000 $98,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.